Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effectiveness of Conventional Versus Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia

NCT02964325 is registered in ClinicalTrials.gov with Terumo BCTbio as lead sponsor.

NCT NCT02964325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02964325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effectiveness of Conventional Versus Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia
Lead sponsor
Terumo BCTbio
Phase
Not applicable
Overall status
Terminated
Start date
May 5, 2017
Completion date
June 25, 2020
Enrollment
422 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic malignancies, hypoproliferative thrombocytopenia